Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
TransMedics Group, Inc. TMDX
$75.31
-$1.72 (-2.29%)
На 18:01, 12 мая 2023
-32.28%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
2515579440.00000000
-
week52high
90.15
-
week52low
23.96
-
Revenue
93459000
-
P/E TTM
-84
-
Beta
1.43711200
-
EPS
-1.21000000
-
Last Dividend
0.00000000
-
Next Earnings Date
31 июл 2023 г. в 20:00
Описание компании
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Morgan Stanley | Equal-Weight | Equal-Weight | 03 авг 2022 г. |
| Oppenheimer | Outperform | Outperform | 02 авг 2022 г. |
| JP Morgan | Overweight | Neutral | 02 авг 2022 г. |
| Cowen & Co. | Outperform | Outperform | 26 июл 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 29 июн 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 11 окт 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 04 ноя 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 06 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Carey John F | D | 13543 | 47 | 01 февр 2023 г. |
| Carey John F | D | 4887 | 1363 | 01 февр 2023 г. |
| Carey John F | D | 14120 | 214 | 01 февр 2023 г. |
| Carey John F | D | 14334 | 139 | 01 февр 2023 г. |
| Carey John F | D | 14473 | 96 | 01 февр 2023 г. |
| Carey John F | D | 14569 | 379 | 01 февр 2023 г. |
| Carey John F | D | 14948 | 582 | 01 февр 2023 г. |
| Carey John F | A | 15530 | 47 | 01 февр 2023 г. |
| Carey John F | A | 15483 | 1363 | 01 февр 2023 г. |
| Gordon Stephen | D | 20728 | 5000 | 01 февр 2023 г. |
Новостная лента
Is TransMedics Group Stock a Buy on the Dip?
The Motley Fool
05 мая 2023 г. в 05:23
TransMedics Group reported impressive first-quarter earnings on May 1, but the stock slipped anyway. TransMedics Group markets an organ-care system that is approved to transport donated hearts, lungs, and livers, and sales of the technology are soaring.
Transmedics Group, Inc. (TMDX) Q1 2023 Earnings Call Transcript
Seeking Alpha
02 мая 2023 г. в 01:05
Transmedics Group, Inc. (NASDAQ:TMDX ) Q1 2023 Earnings Conference Call May 1, 2023 4:30 PM ET Company Participants Brian Johnston - Gilmartin Group Waleed Hassanein - Founder, President, CEO & Director Stephen Gordon - CFO, Treasurer & Secretary Conference Call Participants William Plovanic - Canaccord Genuity Allen Gong - JPMorgan Chase & Co. Cecilia Furlong - Morgan Stanley Suraj Kalia - Oppenheimer Operator Good afternoon, and welcome to TransMedics First Quarter 2023 Earnings Conference Call. [Operator Instructions].
TransMedics (TMDX) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
01 мая 2023 г. в 19:01
TransMedics (TMDX) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to loss of $0.38 per share a year ago.
Strength Seen in TransMedics (TMDX): Can Its 12.3% Jump Turn into More Strength?
Zacks Investment Research
24 апр 2023 г. в 06:05
TransMedics (TMDX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Is TransMedics a Good Stock to Buy Right Now?
The Motley Fool
24 февр 2023 г. в 10:40
This is more than just a medical device manufacturer.